These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 14765332)
1. [Is the supplementation with antioxidants effective in the treatment of atherosclerosis?]. Schröder S Dtsch Med Wochenschr; 2004 Feb; 129(7):321-6. PubMed ID: 14765332 [TBL] [Abstract][Full Text] [Related]
4. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Antoniades C; Tousoulis D; Tentolouris C; Toutouzas P; Stefanadis C Herz; 2003 Nov; 28(7):628-38. PubMed ID: 14689123 [TBL] [Abstract][Full Text] [Related]
5. [Overview of cardiovascular risk factors]. De la Figuera von Wichmann M; Llisterri Caro JL Med Clin (Barc); 2006 Nov; 127(20):774-5. PubMed ID: 17198664 [No Abstract] [Full Text] [Related]
6. Oxidative stress and the role of antioxidants in cardiovascular risk reduction. Schoonover LL Prog Cardiovasc Nurs; 2001; 16(1):30-2. PubMed ID: 11252875 [No Abstract] [Full Text] [Related]
7. Don't keep that ACE (inhibitor) up your sleeve! Is ramipril effective for secondary prevention of cardiovascular disease and stroke? Hammett DC; MacFadyen JC Can Fam Physician; 2000 Apr; 46():821-3. PubMed ID: 10790814 [No Abstract] [Full Text] [Related]
8. [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)]. Perepech NB Kardiologiia; 2004; 44(3):106-10. PubMed ID: 15489840 [No Abstract] [Full Text] [Related]
10. Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Clarke R; Armitage J Cardiovasc Drugs Ther; 2002 Sep; 16(5):411-5. PubMed ID: 12652110 [TBL] [Abstract][Full Text] [Related]
11. [Vascular patient with high infarction risk. Does the AT-1 blocker protect as well as an ACE inhibitor?]. MMW Fortschr Med; 2003 Dec; 145(51-52):39. PubMed ID: 14974331 [No Abstract] [Full Text] [Related]
12. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials]. Lièvre M Rev Prat; 2001 Oct; 51(16):1793-9. PubMed ID: 11795124 [TBL] [Abstract][Full Text] [Related]
14. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension]. MMW Fortschr Med; 2006 Jun; 148(26):50-1. PubMed ID: 16875381 [No Abstract] [Full Text] [Related]
15. [Results of the RALES trial: good news for patients with heart failure and ... for health administrations]. Azpitarte Almagro J Med Clin (Barc); 2000 Apr; 114(14):545-50. PubMed ID: 10846668 [No Abstract] [Full Text] [Related]
16. Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients. Borghi C; Omboni S; Novo S; Vinereanu D; Ambrosio G; Ambrosioni E; Cardiovasc Ther; 2016 Apr; 34(2):76-84. PubMed ID: 26789425 [TBL] [Abstract][Full Text] [Related]
17. Antioxidant vitamins in the prevention of cardiovascular disease. The epidemiological evidence. Price JE; Fowkes FG Eur Heart J; 1997 May; 18(5):719-27. PubMed ID: 9152642 [No Abstract] [Full Text] [Related]
18. [ACE inhibitors for diabetic patients. passed the test on the heart and kidneys]. MMW Fortschr Med; 2002 Oct; 144(44):53. PubMed ID: 12494601 [No Abstract] [Full Text] [Related]